1424 related articles for article (PubMed ID: 32229246)
1. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A
FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639
[TBL] [Abstract][Full Text] [Related]
3. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
4. BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.
Alcarraz-Vizán G; Castaño C; Visa M; Montane J; Servitja JM; Novials A
Cell Mol Life Sci; 2017 Aug; 74(15):2827-2838. PubMed ID: 28337562
[TBL] [Abstract][Full Text] [Related]
5. RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.
Mukherjee N; Contreras CJ; Lin L; Colglazier KA; Mather EG; Kalwat MA; Esser N; Kahn SE; Templin AT
Mol Metab; 2024 Feb; 80():101877. PubMed ID: 38218538
[TBL] [Abstract][Full Text] [Related]
6. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
[TBL] [Abstract][Full Text] [Related]
7. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.
Westwell-Roper CY; Chehroudi CA; Denroche HC; Courtade JA; Ehses JA; Verchere CB
Diabetologia; 2015 Mar; 58(3):575-85. PubMed ID: 25491100
[TBL] [Abstract][Full Text] [Related]
8. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
Westwell-Roper CY; Ehses JA; Verchere CB
Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
[TBL] [Abstract][Full Text] [Related]
9. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
[TBL] [Abstract][Full Text] [Related]
10. 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity.
de Pablo S; Rodríguez-Comas J; Díaz-Catalán D; Alcarraz-Vizán G; Castaño C; Moreno-Vedia J; Montane J; Parrizas M; Servitja JM; Novials A
Sci Rep; 2021 Jun; 11(1):11878. PubMed ID: 34088954
[TBL] [Abstract][Full Text] [Related]
11. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
[TBL] [Abstract][Full Text] [Related]
12. PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.
Chen YC; Mains RE; Eipper BA; Hoffman BG; Czyzyk TA; Pintar JE; Verchere CB
Diabetologia; 2020 Mar; 63(3):561-576. PubMed ID: 31984442
[TBL] [Abstract][Full Text] [Related]
13. Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice.
Castillo JJ; Aplin AC; Hackney DJ; Hogan MF; Esser N; Templin AT; Akter R; Kahn SE; Raleigh DP; Zraika S; Hull RL
Diabetologia; 2022 Oct; 65(10):1687-1700. PubMed ID: 35871651
[TBL] [Abstract][Full Text] [Related]
14. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
[TBL] [Abstract][Full Text] [Related]
15. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
[TBL] [Abstract][Full Text] [Related]
16. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
[TBL] [Abstract][Full Text] [Related]
17. Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3.
Law E; Lu S; Kieffer TJ; Warnock GL; Ao Z; Woo M; Marzban L
Diabetologia; 2010 Jul; 53(7):1415-27. PubMed ID: 20369225
[TBL] [Abstract][Full Text] [Related]
18. cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.
Subramanian SL; Hull RL; Zraika S; Aston-Mourney K; Udayasankar J; Kahn SE
Diabetologia; 2012 Jan; 55(1):166-74. PubMed ID: 22038516
[TBL] [Abstract][Full Text] [Related]
19. Combination of human tau and islet amyloid polypeptide exacerbates metabolic dysfunction in transgenic mice.
Wijesekara N; Gonçalves RA; Ahrens R; Ha K; De Felice FG; Fraser PE
J Pathol; 2021 Jul; 254(3):244-253. PubMed ID: 33797777
[TBL] [Abstract][Full Text] [Related]
20. Amyloid formation reduces protein kinase B phosphorylation in primary islet β-cells which is improved by blocking IL-1β signaling.
Zhang Y; Warnock GL; Ao Z; Park YJ; Safikhan N; Ghahary A; Marzban L
PLoS One; 2018; 13(2):e0193184. PubMed ID: 29474443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
